Study to Assess the Efficacy and Safety of Allogeneic Osteoblastic Cells (ALLOB®) Single Implantation in Tibial Fracture
Clinical trial NCT04432389 · UNKNOWN
Trial details
- NCT number
- NCT04432389
- Sponsor
- Bone Therapeutics S.A
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-08
- Primary completion
- 2022-07-31
- Enrollment
- 178
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.